Rosie Higgins active positions
| Companies | Position | Start | End |
|---|---|---|---|
Syntensor Ltd
 Syntensor Ltd Miscellaneous Commercial ServicesCommercial Services Syntensor Ltd is a British company that develops machine learning methods combined with first-principles thinking in biology to assist drug developers, clinicians, and physicians in answering fundamental questions. The company was founded by Clayton Rabideau and Rosie Higgins, with Clayton Rabideau serving as CEO since incorporation. | Founder | - | - |
| Corporate Officer/Principal | 2021-02-28 | - |
Career history of Rosie Higgins
Former positions of Rosie Higgins
| Companies | Position | Start | End |
|---|---|---|---|
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Chief Operating Officer | - | - |
Statistics
International
| United Kingdom | 3 |
Operational
| Chief Operating Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Technology Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
BenevolentAI Ltd.
BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Technology Services |
Syntensor Ltd
Syntensor Ltd Miscellaneous Commercial ServicesCommercial Services Syntensor Ltd is a British company that develops machine learning methods combined with first-principles thinking in biology to assist drug developers, clinicians, and physicians in answering fundamental questions. The company was founded by Clayton Rabideau and Rosie Higgins, with Clayton Rabideau serving as CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Rosie Higgins
- Experience
